Skip to main content
Equibles

RAYMOND JAMES FINANCIAL INC

Position in ARDX — Ardelyx, Inc.

CIK 720005 ST. PETERSBURG, FL
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,869,626
-$45,778 QoQ
Shares Held
562,672
+15.6% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 250 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Derivatives in ARDX

reported options exposure · as of Jun 30, 2026
CallValue
$255,000
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RAYMOND JAMES FINANCIAL INC holds $1,702,332,948 across 201 Biotechnology names. ARDX ranks #69 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 556,876 $276,617,014
2 ALNY
Alnylam Pharmaceuticals, Inc.
 392,799 $118,244,281
3 REGN
Regeneron Pharmaceuticals, Inc.
 172,896 $107,807,571
4 RPRX
Royalty Pharma plc
 1,599,881 $89,705,325
5 INSM
INSMED Inc
 660,601 $70,433,276
6 KRYS
Krystal Biotech, Inc.
 158,675 $58,974,733
7 JAZZ
Jazz Pharmaceuticals plc
 228,645 $55,096,584
8 EXEL
Exelixis, Inc.
 941,571 $51,230,875

All Filings in ARDX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $255,000 50,000
2026-06-30 $2,869,626 562,672
2026-03-31 $2,915,404 486,712
2026-03-31 $299,500 50,000
2025-12-31 $1,129,672 193,769
2025-09-30 $495,799 89,982
2025-06-30 $805,386 205,456
2025-03-31 $970,318 197,621
2024-12-31 $930,293 183,490